Volpara Health Technologies (“Volpara,” “the Group,” or “the Company”; ASX:VHT), a global leader in software for the early detection of breast cancer, today announced that it has signed five-year contracts with five of North America’s leading healthcare providers, representing over US$7.8M in TCV (NZ$12.3M1).
The new volume-based contracts include the full breadth of Volpara software: Deal Customer Description Contracted software TCV Bon Secours Mercy Health The United States’ fifth largest Catholic health care ministry with 48 hospitals is one of the nation’s 20 largest health care systems Volpara Risk Pathways™ US$1.55M
Adventist Health A faith-inspired, non-profit integrated health system serving more than 80 communities on the West Coast and Hawaii Volpara Patient Hub™ Volpara Risk Pathways™ Volpara Scorecard™ US$1.69M
Northside Hospital One of Georgia’s leading health care systems serving 5 million patient annually. Volpara Patient Hub™ Volpara Risk Pathways™ Volpara Scorecard™ US$1.93M
Duly Health and Care The largest independent, multi-specialty physiciandirected medical group in the Midwest Volpara Analytics™ Volpara Risk Pathways™ Volpara Scorecard™ US$1.45M
Onsite Women’s Health An innovator in the delivery of breast health services through a collaborative care model partnering with OB/GYN and primary care practices nationwide Volpara Analytics™ Volpara Scorecard™ US$1.19M
The company also announces that Centura Health, a 19-hospital health system serving patients across Colorado and western Kansas, has renewed for an additional five-years. The contract is a further US$887K (NZ$1.4M1) in TCV.
Volpara Group CEO Teri Thomas said: “Volpara is delighted to partner with such large and wellrespected organisations to save even more families from cancer. The growing demand for Volpara’s breast software, which brings together cancer risk assessment, density scoring, image quality optimization, and patient tracking and reporting, reflects an industry transformation to more datadriven, personalized, high-quality care.” Thomas adds: “These new contracts are also representative of the “elephant” commercial opportunities Volpara is prioritizing to drive recurring revenue growth. The upgrades and renewals reflect the success providers rely on Volpara to deliver.”
Installation is expected to occur within the next six to twelve months. All contracts are expected to contribute to revenue growth from FY24 onwards and all contracts are for an initial five-year subscription license term with annual payments. Each customer has the right to terminate their contract after 3 years, except for Bon Secours Mercy Health. Consideration paid upon signing for each contract is not considered material.
Source: https://www.volparahealth.com/
